Sonoma Pharmaceuticals (SNOA) Non-Current Debt (2011 - 2022)
Sonoma Pharmaceuticals (SNOA) posted quarterly Non-Current Debt of $15000.0 for Q4 2022, little changed quarter-over-quarter from $15000.0 in Q3 2022.
Sonoma Pharmaceuticals (SNOA) Non-Current Debt (2011 - 2022) Analysis & Trends
Sonoma Pharmaceuticals' Non-Current Debt history runs 11 years deep, the most recent figure standing at $15000.0 for Q4 2022.
- In Q4 2022, Non-Current Debt changed N/A year-over-year to $15000.0; the TTM figure through Dec 2022 stood at $15000.0 (changed N/A YoY), while the FY2021 annual figure was $1.3 million, changed N/A from the prior year.
- Non-Current Debt for Q4 2022 stood at $15000.0, roughly flat from $15000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $1.3 million in Q2 2020, with the low at $12000.0 in Q1 2019.
- The 5-year median for Non-Current Debt is $27000.0 (2018), against an average of $449750.0.
- The sharpest annual moves came in 2018 and 2019: Non-Current Debt decreased 28.89% in 2018, then plunged 62.5% in 2019.
- Sonoma Pharmaceuticals' Non-Current Debt stood at $14000.0 in 2018, then decreased by 14.29% to $12000.0 in 2019, then soared by 10816.67% to $1.3 million in 2020, then changed by 0.0% to $1.3 million in 2021, then sank by 98.85% to $15000.0 in 2022.
- Business Quant data shows SNOA's Non-Current Debt at $15000.0 in Q4 2022, $15000.0 in Q3 2022, and $15000.0 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 130.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 15,000.00 |
| Sep 30, 2022 | 15,000.00 |
| Jun 30, 2022 | 15,000.00 |
| Mar 31, 2021 | 1.31 Mn |
| Dec 31, 2020 | 1.31 Mn |
| Sep 30, 2020 | 1.31 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Mar 31, 2019 | 12,000.00 |
| Dec 31, 2018 | 14,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 29,000.00 |
| Mar 31, 2018 | 32,000.00 |
| Dec 31, 2017 | 35,000.00 |
| Sep 30, 2017 | 39,000.00 |
| Jun 30, 2017 | 42,000.00 |
| Mar 31, 2017 | 45,000.00 |
| Dec 31, 2016 | 48,000.00 |
| Sep 30, 2016 | 50,000.00 |
| Mar 31, 2014 | 4,000.00 |
| Dec 31, 2013 | 12,000.00 |